Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors
Epidermal growth factor receptor (EGFR) is a validated drug target for cancer chemotherapy.
Mutations in EGFR are directly linked with the development of drug resistance and this has …
Mutations in EGFR are directly linked with the development of drug resistance and this has …
Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors
GM Shaikh, M Murahari, S Thakur… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) is a validated drug target for cancer chemotherapy.
Mutations in EGFR are directly linked with the development of drug resistance and this has …
Mutations in EGFR are directly linked with the development of drug resistance and this has …
Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors.
GM Shaikh, M Murahari, S Thakur… - Journal of Molecular …, 2021 - europepmc.org
Epidermal growth factor receptor (EGFR) is a validated drug target for cancer chemotherapy.
Mutations in EGFR are directly linked with the development of drug resistance and this has …
Mutations in EGFR are directly linked with the development of drug resistance and this has …